Bryn Mawr Trust CO Ani Pharmaceuticals Inc Transaction History
Bryn Mawr Trust CO
- $5.51 Billion
- Q2 2025
A detailed history of Bryn Mawr Trust CO transactions in Ani Pharmaceuticals Inc stock. As of the latest transaction made, Bryn Mawr Trust CO holds 28 shares of ANIP stock, worth $2,281. This represents 0.0% of its overall portfolio holdings.
Number of Shares
28Holding current value
$2,281% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding ANIP
# of Institutions
243Shares Held
20.2MCall Options Held
7.4KPut Options Held
12.4K-
Black Rock Inc. New York, NY2.66MShares$216 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.18MShares$96.3 Million0.0% of portfolio
-
Global Alpha Capital Management Ltd.862KShares$70.2 Million3.45% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny818KShares$66.7 Million0.03% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il723KShares$58.9 Million0.01% of portfolio
About ANI PHARMACEUTICALS INC
- Ticker ANIP
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 17,426,000
- Market Cap $1.42B
- Description
- ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. It focuses on producing controlled substances, oncology products, hormones and steroids, injectables, and other formulations. The company manufactures oral solid dose produc...